CD300a Antikörper (PE)
(2 Referenzen)-
- Target Alle CD300a (CD300A) Antikörper anzeigen
- CD300a (CD300A)
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser CD300a Antikörper ist konjugiert mit PE
-
Applikation
- Flow Cytometry (FACS)
- Produktmerkmale
- Purified IgG conjugated to R. Phycoerythrin (RPE)
- Immunogen
- Polyclonal population of NK cells
- Klon
- P192
- Isotyp
- IgG2a
- Top Product
- Discover our top product CD300A Primärantikörper
-
anti-CD300a (CD300A) (AA 18-180) antibody
CD300A Reaktivität: Human ELISA Wirt: Maus Monoclonal 7H8E4 unconjugated
anti-CD300a (CD300A) antibodyCD300A Reaktivität: Human FACS, WB Wirt: Maus Monoclonal MEM-260 unconjugated
anti-CD300a (CD300A) antibody (APC)CD300A Reaktivität: Human FACS Wirt: Maus Monoclonal MEM-260 APC
anti-CD300a (CD300A) antibody (PE)CD300A Reaktivität: Human FACS Wirt: Maus Monoclonal MEM-260 PE
anti-CD300a (CD300A) (AA 1-299) antibodyCD300A Reaktivität: Human WB Wirt: Maus Polyclonal unconjugated
anti-CD300a (CD300A) (Internal Region) antibodyCD300A Reaktivität: Human WB, ELISA, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
-
-
: "Abrogation of allergic reactions by a bispecific antibody fragment linking IgE to CD300a." in: The Journal of allergy and clinical immunology, Vol. 117, Issue 6, pp. 1314-20, (2006) (PubMed).
: "The inhibitory receptor IRp60 (CD300a) is expressed and functional on human mast cells." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 175, Issue 12, pp. 7989-95, (2005) (PubMed).
-
: "Abrogation of allergic reactions by a bispecific antibody fragment linking IgE to CD300a." in: The Journal of allergy and clinical immunology, Vol. 117, Issue 6, pp. 1314-20, (2006) (PubMed).
-
- Target
- CD300a (CD300A)
- Andere Bezeichnung
- CD300a (CD300A Produkte)
- Hintergrund
- Synonyms: IRp60
- Gen-ID
- 11314
- UniProt
- Q9UGN4
- Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
-
